01
Daxiang Biotech and Molecular Devices Establish Joint Innovation R&D Center to Advance Organoid Research
Daxiang Biotech and Molecular Devices, a Danaher company, have taken an important step in strengthening their collaboration with the signing of an agreement to jointly establish an Organoid and Organoid-on-a-Chip Innovation R&D Center, alongside the inauguration of a translational platform in Beijing, China.